{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:07:42Z","timestamp":1764173262467},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[1998,7,1]],"date-time":"1998-07-01T00:00:00Z","timestamp":899251200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur. J. Clin. Microbiol. Infect. Dis."],"published-print":{"date-parts":[[1998,7]]},"DOI":"10.1007\/bf01691138","type":"journal-article","created":{"date-parts":[[2005,5,15]],"date-time":"2005-05-15T06:23:08Z","timestamp":1116138188000},"page":"519-521","source":"Crossref","is-referenced-by-count":13,"title":["Prevalence ofHelicobacter pylori resistance to several antimicrobial agents in a region of Germany"],"prefix":"10.1007","volume":"17","author":[{"given":"K.","family":"Wolle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Nilius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Leodolter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W. A.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Malfertheiner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"BF01691138_CR1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00042737-199409000-00004","volume":"6","author":"F Bazzoli","year":"1994","unstructured":"Bazzoli F, Zagari RM, Fossi S, Pozzato P, Alampi G, Simono P: Short-term, low-dose triple therapy for eradication ofHelicobacter pylori. European Journal of Gastroenterology and Hepatology (1994) 6:773\u2013777","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"BF01691138_CR2","first-page":"1","volume":"7","author":"A Goddard","year":"1995","unstructured":"Goddard A, Logan R: One-week low-dose triple therapy: new standards forHelicobacter pylori treatment. European Journal of Gastroenterology and Hepatology (1995) 7:1\u20133","journal-title":"European Journal of Gastroenterology and Hepatology"},{"key":"BF01691138_CR3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1136\/gut.35.3.323","volume":"35","author":"RP Logan","year":"1994","unstructured":"Logan RP, Gummett PA, Schaufelberger HD, Greaves RR, Mendelson GM, Thomas PH, Baron JH, Misiewicz JJ: Eradication ofHelicobacter pylori with clarithromycin and omeprazole. Gut (1994) 35:323\u2013326","journal-title":"Gut"},{"issue":"Supplement 68","key":"BF01691138_CR4","first-page":"A68","volume":"108","author":"R Cayla","year":"1995","unstructured":"Cayla R, Zerbib F, Talbi P, Megraud F, Lamouliatte H: Clarithromycin resistance ofHelicobacter pylori strains before and after treatment: a key factor of treatment failures. Gastroenterology (1995) 108: Supplement 68:A68","journal-title":"Gastroenterology"},{"key":"BF01691138_CR5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.3109\/00365549409011802","volume":"26","author":"LA Noach","year":"1994","unstructured":"Noach LA, Langenberg WL, Bertola MA, Dankert J, Tytgat GNJ: Impact of metronidazole resistance on the eradication ofHelicobacter pylori. Scandinavian Journal of Infectious Diseases (1994) 26:321\u2013327","journal-title":"Scandinavian Journal of Infectious Diseases"},{"key":"BF01691138_CR6","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1007\/978-94-011-1418-9_54","volume-title":"Helicobacter pylori. Basic mechanisms to clinical cure","author":"FH Megraud","year":"1994","unstructured":"Megraud FH:H. pylori resistance to antibiotics. In: Hunt RH, Tytgat GNJ (eds).Helicobacter pylori. Basic mechanisms to clinical cure. Kluwer Academic Publishers, Dordrecht (1994) pp. 570\u2013583"},{"key":"BF01691138_CR7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1440-1746.1996.tb00078.x","volume":"11","author":"PD Midolo","year":"1996","unstructured":"Midolo PD, Lambert JR, Turnbridge J: Metronidazole resistance: predictor of failure ofHelicobacter pylori eradication by triple therapy. Journal of Gastroneterology and Hepatology (1996) 11:290\u2013292","journal-title":"Journal of Gastroneterology and Hepatology"},{"key":"BF01691138_CR8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/jac\/31.1.65","volume":"31","author":"G Cederbrant","year":"1993","unstructured":"Cederbrant G, Kahlmeter G, Ljungh A: The E-test for antimicrobial susceptibility testing ofHelicobacter pylori. Journal of Antimicrobial Chemotherapy (1993) 31:65\u201371","journal-title":"Journal of Antimicrobial Chemotherapy"},{"key":"BF01691138_CR9","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1128\/JCM.29.9.2072-2075.1991","volume":"29","author":"Y Glupczynski","year":"1991","unstructured":"Glupczynski Y, Labbe M, Hansen W, Crokaert F, Yourassowsky E: Evaluation of the E-test for quantitative antimicrobial susceptibility testing ofHelicobacter pylori. Journal of Clinical Microbiology (1991) 29:2072\u20132075","journal-title":"Journal of Clinical Microbiology"},{"key":"BF01691138_CR10","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1136\/jcp.41.2.207","volume":"41","author":"CS Goodwin","year":"1988","unstructured":"Goodwin CS, Marshall BJ, Blincow ED, Wilson DH, Blackburn S, Phillips M: Prevention of nitroimidazole resistance inCampylobacter pylori by coadministration of colloidal bismuth subcitrate: clinical and in vitro studies. Journal of Clinical Pathology (1988) 41:207\u2013210","journal-title":"Journal of Clinical Pathology"},{"key":"BF01691138_CR11","first-page":"165","volume":"35","author":"B Tillenburg","year":"1997","unstructured":"Tillenburg B, Siehoff S, Becker T, Peitz U, B\u00f6rsch G, Labenz J:Helicobacter pylori: the situation of pretherapeutical resistance rates in Germany (Ruhr area). German Journal of Gastroenterology (1997) 35:165\u2013169","journal-title":"German Journal of Gastroenterology"},{"key":"BF01691138_CR12","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/BF01960875","volume":"11","author":"Y Glupczynski","year":"1992","unstructured":"Glupczynski Y: Results of a multicentre European survey in 1991 of metronidazole resistance inHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases (1992) 11:777\u2013781","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"BF01691138_CR13","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/BF01691216","volume":"15","author":"AA Zwet van","year":"1996","unstructured":"van Zwet AA, de Boer WA, Schneeberger PM, Weel J, Jansz AR, Thijs JC: Prevalence of primaryHelicobacter pylori resistance to metronidazole and clarithromycin in the Netherlands. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:861\u2013864","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"BF01691138_CR14","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/BF01690512","volume":"15","author":"T Alarcon","year":"1996","unstructured":"Alarcon T, Domingo D, Sanchez I, Diaz de Rojos F, Lopez-Brea M: In vitro activity of omeprazole in combination with several antimicrobial agents against clinical isolates ofHelicobacter pylori. European Journal of Clinical Microbiology & Infectious Diseases (1996) 15:937\u2013940","journal-title":"European Journal of Clinical Microbiology & Infectious Diseases"},{"key":"BF01691138_CR15","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/S0140-6736(96)90657-1","volume":"347","author":"PD Midolo","year":"1996","unstructured":"Midolo PD, Korman MG, Turnidge JD, Lambert JR:Helicobacter pylori resistance to tetracycline. Lancet (1996) 347:1194\u20131195","journal-title":"Lancet"}],"container-title":["European Journal of Clinical Microbiology & Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01691138.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF01691138\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF01691138","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T10:11:21Z","timestamp":1586254281000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF01691138"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,7]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1998,7]]}},"alternative-id":["BF01691138"],"URL":"https:\/\/doi.org\/10.1007\/bf01691138","relation":{},"ISSN":["0934-9723","1435-4373"],"issn-type":[{"value":"0934-9723","type":"print"},{"value":"1435-4373","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,7]]}}}